日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients

靶向 miR-223 可增强多发性硬化症患者髓系来源抑制细胞的抑制活性

期刊:Multiple Sclerosis and Related Disorders
影响因子:2.9
doi:10.1016/j.msard.2023.104839
Cantoni, Claudia; Ghezzi, Laura; Choi, Jasmine; Cross, Anne H; Piccio, Laura
神经科学
细胞生物学
多发性硬化症
发表日期：2023
文献求助 收藏

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea

地塞米松玻璃体内植入剂治疗视网膜静脉阻塞后黄斑水肿：韩国真实世界上市后监测数据的后验分析

期刊:
影响因子:
doi:10.2147/OPTH.S302014
Kim, Min Seok; Choi, Jasmine; Lee, Hyeong Du; Woo, Se Joon
发表日期：2021
文献求助 收藏

Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial

根据基线风险评估每周一次艾塞那肽治疗对2型糖尿病患者临床结局的影响：来自EXSCEL试验的启示

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.118.009304
Mentz, Robert J; Bethel, M Angelyn; Merrill, Peter; Lokhnygina, Yuliya; Buse, John B; Chan, Juliana C; Felício, João S; Goodman, Shaun G; Choi, Jasmine; Gustavson, Stephanie M; Iqbal, Nayyar; Lopes, Renato D; Maggioni, Aldo P; Öhman, Peter; Pagidipati, Neha J; Poulter, Neil R; Ramachandran, Ambady; Reicher, Barry; Holman, Rury R; Hernandez, Adrian F
CEL
糖尿病
代谢
发表日期：2018
文献求助 收藏

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

每周一次艾塞那肽对2型糖尿病患者心血管结局的影响

期刊:New England Journal of Medicine
影响因子:78.5
doi:10.1056/NEJMoa1612917
Holman, Rury R; Bethel, M Angelyn; Mentz, Robert J; Thompson, Vivian P; Lokhnygina, Yuliya; Buse, John B; Chan, Juliana C; Choi, Jasmine; Gustavson, Stephanie M; Iqbal, Nayyar; Maggioni, Aldo P; Marso, Steven P; Öhman, Peter; Pagidipati, Neha J; Poulter, Neil; Ramachandran, Ambady; Zinman, Bernard; Hernandez, Adrian F
代谢
糖尿病
发表日期：2017
文献求助 收藏

A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy

一项随机、双盲、III期研究比较了英夫利昔单抗生物类似药SB2与英夫利昔单抗参考产品Remicade在接受甲氨蝶呤治疗后仍患有中重度类风湿性关节炎的患者中的疗效。

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2015-207764
Choe, Jung-Yoon; Prodanovic, Nenad; Niebrzydowski, Jaroslaw; Staykov, Ivan; Dokoupilova, Eva; Baranauskaite, Asta; Yatsyshyn, Roman; Mekic, Mevludin; Porawska, Wieskawa; Ciferska, Hana; Jedrychowicz-Rosiak, Krystyna; Zielinska, Agnieszka; Choi, Jasmine; Rho, Young Hee; Smolen, Josef S
关节炎
发表日期：2017
文献求助 收藏

Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results

一项为期 54 周的双盲试验比较了生物类似药 SB2 与参考药物英夫利昔单抗：临床、结构和安全性结果

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/kex254
Smolen, Josef S; Choe, Jung-Yoon; Prodanovic, Nenad; Niebrzydowski, Jaroslaw; Staykov, Ivan; Dokoupilova, Eva; Baranauskaite, Asta; Yatsyshyn, Roman; Mekic, Mevludin; Porawska, Wieskawa; Ciferska, Hana; Jedrychowicz-Rosiak, Krystyna; Zielinska, Agnieszka; Choi, Jasmine; Rho, Young Hee
发表日期：2017
文献求助 收藏

Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.

硝苯地平/替米沙坦联合治疗对高危高血压患者的微量白蛋白尿和 sRAGE 的影响：TALENT 的一项子研究

期刊:Mediators of Inflammation
影响因子:4.2
doi:10.1155/2012/874149
Falcone Colomba, Buzzi Maria Paola, Bozzini Sara, Boiocchi Chiara, D'Angelo Angela, Schirinzi Sandra, Esposito Ciro, Torreggiani Massimo, Choi Jasmine, Ochan Kilama Michael, Mancia Giuseppe
心血管
高血压
发表日期：2012
文献求助 收藏